Paraneoplastic Glomerular Diseases.


Journal

Advances in kidney disease and health
ISSN: 2949-8139
Titre abrégé: Adv Kidney Dis Health
Pays: United States
ID NLM: 9918523075306676

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 01 02 2024
revised: 25 04 2024
accepted: 30 04 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 31 7 2024
Statut: ppublish

Résumé

Paraneoplastic glomerular disease (PGD) develops from tumor cell products, leading to renal dysfunction. Unlike direct tumor effects, PGD illustrates the complex association between cancer and diverse clinical presentations and outcomes. Initially detected in a Hodgkin's disease patient, current research has defined diagnostic criteria based on PGD symptoms and cancer progression. PGDs, although rare (found in <1% of adult cancer patients with overt renal manifestations), are crucial, as they can signal cancer onset and frequently resist standard glomerulonephritis treatments. The emerging field of onconephrology studies this relationship between kidney disorders and cancers. The exact cause of many PGD cases remains unknown. This review examines PGDs, their clinicopathological features, related cancers, and mechanisms, emphasizing the need for early diagnosis and tailored treatment for kidney disease and linked cancer.

Identifiants

pubmed: 39084760
pii: S2949-8139(24)00082-X
doi: 10.1053/j.akdh.2024.04.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

346-357

Informations de copyright

Copyright © 2024 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Aarthi Muthukumaran (A)

Division of Nephrology, Hammersmith Hospital, Imperial College Healthcare, NHS, London, UK.

Rimda Wanchoo (R)

Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY.

Surya V Seshan (SV)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY.

Prakash Gudsoorkar (P)

Division of Nephrology, University of Cincinnati, OH. Electronic address: GUDSOOPS@ucmail.uc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH